U.S. Clinical Nutrition MarketSize and Trends
U.S. clinical nutrition market is estimated to be valued at US$ 4.93 Bn in 2023 and is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).
Figure 1. U.S. Clinical Nutrition Market Share (%), By Type, 2023
![](/images/research-%20methodology/168973u.s.-clinical-nutrition-market-figure-1.png)
U.S. Clinical Nutrition Market– Drivers
- Rising number of business development strategies by market players: Key players operating in the U.S. clinical nutrition market are adopting several business development strategies such as product launch to expand their product offerings, and this is expected to fuel the market growth over the forecast period. For instance, in June 2020, Otsuka Pharmaceutical Factory Inc., a pharmaceutical company, announced the launch of its new ENORAS Liquid for enteral use in coffee flavor and strawberry flavor. It is indicated for nutritional support in postoperative patients.
- Increasing prevalence of cancer: Increasing changes in lifestyles is considered a major cause of cancer. Thus, increasing prevalence of cancer globally is expected to boost growth of the U.S clinical nutrition market over the forecast period, as arrays are used in diagnostics for various indications such as cancer and others. For instance, in 2021, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below
ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021
Figure 2. U.S. Clinical Nutrition Market Share (%), By Application, 2023
![](/images/research-%20methodology/710400u.s.-clinical-nutrition-market-figure-2.png)